Alternative Investments - Gold, REITs, Crypto, Commodities, etc.

Tag: dividend stocks

KBDC stock analysis showing a 12.3% yield, $5.2M Jim Robo insider buy and deep NAV discount against rising private-credit risks.

🏦 Kayne Anderson BDC (KBDC): A $5.2M Insider Buy, 12.3% Yield—and the BDC Trap 💰⚡

Kayne Anderson BDC Chairman Jim Robo just put $5.2 million behind KBDC near $13. Add a 12.3% yield, deep discount to NAV and covered dividend, and the stock looks irresistible—until you examine NAV erosion, leverage and private-credit risk.

 

Read entire article

Tags: BDC, business development companies, buy or sell KBDC, CarpeDiem, credit risk, dividend stocks, dividend yield, DividendInvesting, featured-diversify, featured-insiders, FUNanc1al, FunStock Index, FunStock Method, high yield stocks, HighYield, hub-diversify, hub-insiders, income investing, insider buying, insider purchases, Jim Robo, JimRobo, Kayne Anderson BDC, Kayne Anderson BDC stock, KayneAnderson, KBDC, KBDC stock, NAV, NAV discount, net asset value, net investment income, NII, private credit, PrivateCredit, risks buying KBDC, value investing, ValueInvesting, why buy KBDC
Illustration of a futuristic life science research campus under reconstruction, with cranes and glowing laboratory buildings, symbolizing Alexandria Real Estate’s turnaround in biotech real estate.

Alexandria Real Estate (ARE): The Life Science “Dr. Frankenstein” Pivot — Rebuilding the Lab from the Floor Up

Alexandria Real Estate (ARE) is the king of life science labs—and one of the most punished REITs of the last five years. After a brutal dividend cut, asset write-downs, and a 75% drawdown, the founder just bought $1.3M of stock and the company is buying back shares. Is this a broken experiment—or a classic cycle-bottom setup?

 

Read entire article

Tags: Alexandria Real Estate, ARE, Biotech, Biotech Real Estate, BiotechInvesting, BiotechTurnarounds, buy or sell ARE, Dividend Stocks, featured-diversify, featured-insiders, FUNanc1al, FUNanc1al Edge, Healthcare Real Estate, hub-diversify, hub-insiders, Income Investing, Insider Buying, Lab Space, Life Science REIT, Real Estate Investing, REIT, risks buying ARE, Stock Analysis, Turnaround Stocks, Value Investing, why buy ARE
Cartoon-style digital illustration of a Bunge-branded tractor harvesting moneybags from a golden cornfield labeled “Dividends,” while institutional investors in suits chase behind with pitchforks and a banner reading “Merger, Anyone?”

Bunge: Time for the Big Binge?

🛢️ Agribusiness giant Bunge is getting squeezed—but don’t count it out yet. With a massive merger on deck, insider and institutional support strong, and shares trading at low multiples, could it be time for a contrarian feast?

Read entire article

Tags: Agribusiness Stocks, BG stock, Bunge Global, Bunge Viterra Merger, Commodities and Agriculture, Contrarian Picks, dividend stocks, Food Commodities, Funanc1al Contrarian Picks, Funanc1al Contrarian Plays, Funanc1al Edge, Funanc1al for Investors, Funanc1al Investing, Funanc1alEdge, Funanc1alInvesting, Funanc1alStocks, Glencore Viterra Merger, Institutional Ownership, Shareholder Returns, Stock Market Humor, Value Investing